NCT01572025 - Dehydroepiandrosterone (DHEA) Intervention To Treat Ovarian Aging | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

InfertilityOvarian AgingDiminished Ovarian Reserve (DOR)Predicted Poor-responders

Interventions

DRUG

Dehydroepiandrosterone

"Dehydroepiandrosterone (DHEA)(St Mary's Pharmaceutical Unit Cardiff and Vale) DHEA 75 mg capsule. 1 capsule taken once daily for at least 12 weeks prior commencing ovarian stimulation protocol~: Stimulation protocol standard long down-regulation protocol, using human menopausal gonadotropin (HMG)"

DRUG

Placebo

"Matched Placebo containing no active ingredient. 1 capsule taken once daily for at least 12 weeks prior commencing ovarian stimulation protocol~: Stimulation protocol standard long down-regulation protocol, using human menopausal gonadotropin (HMG)"

Trial Locations (1)

NG7 2UH

Nottingham University Research and Treatment Unit in Reproduction (NURTURE), Nottingham

All Listed Sponsors

lead

University of Nottingham

OTHER